Literature DB >> 80226

Effect of chelating agents and metal ions on the degradation of DNA by bleomycin.

E A Sausville, J Peisach, S B Horwitz.   

Abstract

The degradation of DNA by bleomycin was studied in the absence and in the presence of added reducing agents, including 2-mercaptoethanol, dithiothreitol, reduced nicotinamide adenine dinucleotide phosphate, H2O2, and ascorbate, and in the presence of a superoxide anion generating system consisting of xanthine oxidase and hypoxanthine. In all cases, breakage of DNA was inhibited by low concentrations of chelators; where examined in detail, deferoxamine mesylate was considerably more potent than (ethylenedinitrilo)tetraacetic acid. Iron was found to be present in significant quantities in all reaction mixtures. Thus, the pattern of inhibition observed is attributed to the involvement of contaminating iron in the degradation of DNA by bleomycin. Cu(II), Zn(II), and Co(II) inhibit degradation of DNA by bleomycin and Fe(II) in the absence of added reducing agents. A model is proposed in which the degradation of DNA in these systems is dependent on the oxidation of an Fe(II)-bleomycin-DNA complex.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80226     DOI: 10.1021/bi00607a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  NC1404, a novel derivative of Bleomycin with modified sugar moiety obtained during the preparation of Boningmycin.

Authors:  Xin Qi; Xinwei Wang; Hao Ren; Feng Zhang; Xiumin Zhang; Ning He; Wenqiang Guo; Ruxian Chen; Yunying Xie; Qiyang He
Journal:  J Antibiot (Tokyo)       Date:  2017-05-31       Impact factor: 2.649

2.  Oxygen radical formation and DNA damage due to enzymatic reduction of bleomycin-Fe(III).

Authors:  I Mahmutoglu; M E Scheulen; H Kappus
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

3.  Filamin-A as a marker and target for DNA damage based cancer therapy.

Authors:  Jingyin Yue; Huimei Lu; Jingmei Liu; Marianne Berwick; Zhiyuan Shen
Journal:  DNA Repair (Amst)       Date:  2011-11-02

4.  Quantitative measurement of single- and double-strand breakage of DNA in Escherichia coli by the antitumor antibiotics bleomycin and talisomycin.

Authors:  C K Mirabelli; C H Huang; R G Fenwick; S T Crooke
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 5.  Mechanism of DNA-drug interactions.

Authors:  P Prabhakar; A M Kayastha
Journal:  Appl Biochem Biotechnol       Date:  1994-04       Impact factor: 2.926

6.  The response of ataxia telangiectasia cells to bleomycin.

Authors:  A R Lehmann; S Stevens
Journal:  Nucleic Acids Res       Date:  1979       Impact factor: 16.971

7.  Structural studies of of "active complex" of bleomycin: assignment of ligands to the ferrous ion in a ferrous-bleomycin-carbon monoxide complex.

Authors:  N J Oppenheimer; L O Rodriguez; S M Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

Review 8.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

9.  Characterization of an Fe III-OOH species and its decomposition product in a bleomycin model system.

Authors:  Michael R Bukowski; Shourong Zhu; Kevin D Koehntop; William W Brennessel; Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2003-10-15       Impact factor: 3.358

Review 10.  Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae.

Authors:  Dindial Ramotar; Huijie Wang
Journal:  Curr Genet       Date:  2003-04-16       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.